The van der Schaar Lab’s ninth Revolutionizing Healthcare engagement session for clinicians took place virtually on July 13, 2021.
This session featured an international panel of 5 clinicians who discussed AI and machine learning decision support tools for diseases such as breast cancer. One such tool (developed by the van der Schaar lab) is Adjutorium, which was the focus of an extensive study published in Nature Machine Intelligence.
Our panel for this session consisted of:
- Adrian Harris, MD DPhil (Professor of medical oncology, University of Oxford // Consultant medical oncologist, Oxford University Hospitals NHS Foundation Trust)
- Dirk Timmerman, MD PhD (Professor in obstetrics and gynecology at KU Leuven // Visiting professor, Imperial College London)
- Jem Rashbass, MD PhD ([Formerly] Executive director, data and analytical Services, NHS Digital // [Formerly] National director for disease registration and cancer analysis, PHE)
- Kelly McCann, MD PhD (Practicing hematologist-oncologist, University of California Los Angeles (UCLA) // Translational Oncology Research Lab, Ronald Reagan UCLA Medical Center)
- Sileny Han, MD PhD (Gynecologist-oncologist, UZ Leuven // Assistant professor, Faculty of Medicine, KU Leuven)
The session started with presentations on Adjutorium from Mihaela van der Schaar and postdoc Ahmed Alaa, which formed the basis of the subsequent clinician roundtable. During the roundtable, the panelists explored a range of topics related to the clinical application of tools like Adjutorium—such as the kinds of information that would be useful for clinicians and patients, and how this information can be displayed (among a range of other topics).
Introduction – 0:00
Meet the roundtable panelists – 2:26
Declaration of interests – 3:33
Live presentation by Mihaela on AI and machine learning decision-support tools – 4:46
Presentation 1 by Ahmed Alaa [Adjutorium app demonstration] – 16:55
Presentation 2 by Ahmed Alaa [Adjutorium high-level overview] – 23:21
Roundtable discussion part 1 [Uses/applications of Adjutorium and similar tools] – 37:01
Roundtable discussion part 2 [Trustworthiness, robustness, and ease of use] – 49:59
Roundtable discussion part 3 [Adjutorium for patients and healthcare systems] – 57:23
Intro to next sessions and note on CPD credits – 1:03:55
NOTE: This information was up-to-date at the time of the presentation but does not take into account material published since then.
Sign up for our upcoming sessions here.